Universität zu Köln

Journal Article

Berkell, Matilda ORCID: 0000-0002-7096-7896, Mysara, Mohamed ORCID: 0000-0001-5746-4330, Xavier, Basil Britto ORCID: 0000-0002-5897-0240, van Werkhoven, Cornelis H., Monsieurs, Pieter, Lammens, Christine, Ducher, Annie, Vehreschild, Maria J. G. T., Goossens, Herman, de Gunzburg, Jean ORCID: 0000-0001-8049-9283, Bonten, Marc J. M., Malhotra-Kumar, Surbhi, Engbers, Annemarie, de Regt, Marieke, Biehl, Lena M., Cornely, Oliver A., Jazmati, Nathalie, Bouverne, Marie-Noelle, Sablier-Gallis, Frederique, Mentre, France, Merle, Uta, Stallmach, Andreas, Rupp, Jan ORCID: 0000-0001-8722-1233, Bogner, Johannes, Lubbert, Christoph, Silling, Gerda, Witzke, Oliver, Gikas, Achilleas, Maraki, Sofia, Daikos, George, Tsiodras, Sotirios, Skoutelis, Athanasios, Sambatakou, Helen, Pujol, Miguel, Dominguez-Luzon, M. Angeles, Aguado, Jose M., Bouza, Emilio, Cobo, Javier, Rodriguez-Bano, Jesus ORCID: 0000-0001-6732-9001, Almirante, Benito, Cisneros, Julian de la Torre, Florescu, Simin A., Nica, Maria, Vata, Andrei, Hristea, Adriana, Lupse, Mihaela, Herghea, Delia, Postil, Deborah, Barraud, Olivier, Molina, Jean-Michel, De Lastours, Victoire, Guimard, Thomas, Talarmin, Jean-Philippe, Duval, Xavier, Bernard, Louis and Launay, Odile (2021). Microbiota-based markers predictive of development of Clostridioides difficile infection. Nat. Commun., 12 (1). BERLIN: NATURE RESEARCH. ISSN 2041-1723

Bouza, Emilio, Cornely, Oliver A., Ramos-Martinez, Antonio ORCID: 0000-0002-4840-9425, Plesniak, Robert, Ellison, Misoo C., Hanson, Mary E. and Dorr, Mary Beth (2020). Analysis of C. difficile infection-related outcomes in European participants in the bezlotoxumab MODIFY I and II trials. Eur. J. Clin. Microbiol. Infect. Dis., 39 (10). S. 1933 - 1940. NEW YORK: SPRINGER. ISSN 1435-4373

Cornely, Oliver A., Mullane, Kathleen M., Birch, Thomas, Hazan-Steinberg, Sabine, Nathan, Richard, Bouza, Emilio, Calfee, David P., Ellison, Misoo Chung, Wong, Michael T. and Dorr, Mary Beth (2020). Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer. Open Forum Infect. Dis., 7 (2). CARY: OXFORD UNIV PRESS INC. ISSN 2328-8957

Vehreschild, Maria J. G. T., Taori, Surabhi ORCID: 0000-0002-2976-4106, Goldenberg, Simon D., Thalhammer, Florian, Bouza, Emilio ORCID: 0000-0001-6967-9267, van Oene, Joop, Wetherill, Graham and Georgopali, Areti (2018). Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE). Eur. J. Clin. Microbiol. Infect. Dis., 37 (11). S. 2097 - 2107. NEW YORK: SPRINGER. ISSN 1435-4373

van Prehn, Joffrey, Reigadas, Elena, Vogelzang, Erik H., Bouza, Emilio, Hristea, Adriana, Guery, Benoit, Krutova, Marcela, Noren, Torbjorn, Allerberger, Franz, Coia, John E., Goorhuis, Abraham, van Rossen, Tessel M., Ooijevaar, Rogier E., Burns, Karen, Olesen, Bente R. Scharvik, Tschudin-Sutter, Sarah, Wilcox, Mark H., Vehreschild, Maria J. G. T., Fitzpatrick, Fidelma and Kuijper, Ed J. (2021). European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin. Microbiol. Infect., 27. S. S1 - 21. OXFORD: ELSEVIER SCI LTD. ISSN 1469-0691